Importantly, IFNα has been closely associated with numerous neuropsychiatric comorbidities in various clinical contexts, including recombinant IFNα treatment for chronic hepatitis C infection and melanoma [5–7], as well as SLE associated neuropsychiatric disease [8, 9]. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.